September 25, 2026

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges with Strategic Innovation

For investors keeping a close eye on the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a complex yet intriguing picture. With a market capitalization of approximately $396 million, this..

AtaiBeckley Inc. (ATAI) Stock Analysis: A Healthcare Innovator with Potential 10.43% Upside

AtaiBeckley Inc. (ATAI) stands at the forefront of the biotechnology industry, primarily focused on developing groundbreaking treatments for mental health conditions. Operating as a subsidiary of Eli Lilly and Company,..

ArriVent BioPharma, Inc. (AVBP) Investor Outlook: Exploring a 48.50% Potential Upside in the Biotechnology Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a burgeoning player in the biotechnology sector, has caught the attention of investors with its promising pipeline and substantial potential upside of 48.50%. With a..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring the 502% Potential Upside for This Biotechnology Innovator

For investors seeking opportunities in the biotechnology sector, Upstream Bio, Inc. (NASDAQ: UPB) presents a compelling case. This clinical-stage biotech company, headquartered in Waltham, Massachusetts, is dedicated to developing novel..

Xencor, Inc. (XNCR) Investor Outlook: Navigating a 30% Upside in the Biotech Sector

Xencor, Inc. (NASDAQ: XNCR) stands at the forefront of innovation within the biotechnology sector, emphasizing the development of engineered antibodies for cancer and autoimmune disease treatments. As a clinical-stage biopharmaceutical..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a 128% Potential Upside in the Biotech Arena

Nuvation Bio Inc. (NASDAQ: NUVB), with its remarkable market cap of $2.01 billion, is making waves in the biotechnology sector. Based in New York, this clinical-stage biopharmaceutical company is dedicated..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Is a 215% Upside Potential Within Reach?

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to treating diseases like Duchenne Muscular Dystrophy (DMD) and its..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a 31.75% Potential Upside Amid Volatility

AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and significant market moves. Headquartered in Vancouver, Canada, AbCellera specializes..

Orthofix Medical Inc. (OFIX) Investor Outlook: Potential Upside of 41.92% Sparks Interest

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking exposure to innovative medical technologies...

Auna SA (AUNA) Stock Analysis: Exploring a 37.24% Potential Upside in Healthcare Sector

Auna SA (AUNA), a key player in the healthcare sector, is catching the attention of investors with its robust growth trajectory and promising potential upside. Based in Luxembourg, Auna operates..

Rocket Pharmaceuticals (RCKT) Stock Analysis: Exploring a Potential 229% Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a biotechnology company with a promising focus on genetic therapies for rare and devastating diseases. Headquartered in Cranbury, New Jersey, Rocket Pharmaceuticals is making..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Potential Upside of 134% Sparks Investor Interest

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company, is gaining attention in the investor community thanks to its promising drug pipeline and significant upside potential. With a market capitalization..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Can This Biotech Player Overcome Its Revenue Challenges?

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning name in the biotechnology sector, is capturing investor attention as it navigates the complexities of the healthcare industry. Headquartered in Durham, North Carolina,..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating Growth in Health Information Services

Weave Communications, Inc. (NYSE: WEAV) is carving a niche in the healthcare sector with its AI-powered communication and payment solutions tailored for small and medium-sized healthcare businesses. As of recent..

COMPASS Pathways Plc (CMPS): Investor Outlook Reveals 81% Potential Upside

For investors with an eye on the healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS) is a biotechnology company commanding attention. With a market capitalization of $1.81 billion, COMPASS Pathways is..

Zenas BioPharma, Inc. (ZBIO) Investor Outlook: A 70.91% Potential Upside in the Biotech Sector

Zenas BioPharma, Inc. (ZBIO) is making headlines in the biotechnology sector with its innovative approach to developing transformative immunology-based therapies. For investors eyeing the healthcare industry, Zenas represents a fascinating..

EyePoint, Inc. (EYPT) Stock Analysis: Assessing a 609% Potential Upside in the Biotechnology Sector

EyePoint, Inc. (NASDAQ: EYPT), a biotechnology firm focused on developing treatments for serious retinal diseases, has captured significant attention from investors due to its potential upside of 609.84%, as reflected..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A High-Risk, High-Reward Play with 184.75% Potential Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the biotechnology sector, is capturing investor attention with its innovative approach to engineered cell therapies. While its current stock price of..

LifeMD, Inc. (LFMD) Stock Analysis: Unveiling a 179% Potential Upside in the Telehealth Sector

LifeMD, Inc. (NASDAQ: LFMD), a prominent player in the healthcare sector, specifically within the health information services industry, is capturing investor attention with its compelling growth narrative and substantial upside..

Search

Funds

September 25, 2026

Search

Funds

September 25, 2026

FTSE 100

Funds